GlassScriptPhysician profile
Shawn Sabin
NPI 1427002575
$3,782.92
in general payments reported to CMS, 2019-2025
31 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 76% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $411 · 2021: $89.06 · 2022: $308 · 2023: $360 · 2024: $458 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,940.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $707.70 | 2019-2025 | Skyrizi |
| Novartis Pharmaceuticals Corporation | $302.53 | 2019-2023 | |
| Janssen Biotech, INC. | $279.83 | 2019-2025 | Tremfya |
| Ucb, INC. | $276.76 | 2022-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $259.20 | 2019-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $245.63 | 2019-2025 | |
| Kerecis Limited | $214.49 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Almirall LLC | $156.47 | 2019 | |
| Genentech USA, INC. | $148.86 | 2019-2024 | Erivedge |
| Convatec INC. | $146.92 | 2024-2025 | |
| Lilly USA, LLC | $143.18 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Celgene Corporation | $127.20 | 2019 | |
| Galderma Laboratories, L.P. | $106.43 | 2019-2025 | Nemluvio |
| Amgen INC. | $78.50 | 2021-2025 | Otezla, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $71.48 | 2019-2023 | Jublia, Arazlo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $63.83 | 2023-2024 | Opzelura |
| Leo Pharma INC. | $54.82 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.29 | 2023-2024 | Spevigo, Cyltezo |
| Organon LLC | $47.85 | 2025 | |
| Urgo Medical North America, LLC | $44.59 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Pfizer INC. | $42.26 | 2023-2025 | |
| Organogenesis INC. | $36.86 | 2020 | |
| Genzyme Corporation | $36.21 | 2020-2022 | |
| Surgenex LLC | $33.33 | 2025 | Renograft, Ardeograft, Surgraft |
| Aclaris Therapeutics, INC. | $32.30 | 2019 | |
| Biofrontera INC. | $15.86 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.89 | 2019 | |
| Mayne Pharma Commercial LLC | $13.06 | 2020 | |
| Merck Sharp & Dohme LLC | $11.37 | 2019 | |
| Dermira, INC. | $11.11 | 2019 | |
| Journey Medical Corporation | $10.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Sabin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.